Pediatricians in the United States are increasingly finding that antibiotics are not always ideal for treating ear infections, a report says.
The Denver Post reported on the findings, which are significant to pediatricians -- children are highly susceptible to ear infections.
Antibiotics are typically prescribed right away to patients with ear infections, but doctors have reported on an increase in patients and parents who report that these medications have failed to relieve the infection.
Patricia Yoon, a pediatric ear, nose and throat specialist at The Children's Hospital in Denver told the Post that this is cause for real concern because ear infections account for about one-fourth of all antibiotics prescribed in the United States. Yoon said she thinks an increasing number of strains of resistant bacteria are emerging.
But the problem has also been seen beyond ear infections. The Post reported that the antibiotic erythromycin, which fights off skin infections, was shown to work 71 percent of the time in 1996. By 2001, the drug was reportedly effective only 46 percent of the time.
Copyright 2007 by United Press International
Related stories:
Newly identified enzyme treats deadly bacterial infections in mice
By the time antibiotics made their clinical debut 70 years ago, bacteria had long evolved strategies to shield themselves. For billions of years, bacteria hurled toxic molecules at each other in the struggle to prosper, and those that withstood the chemical onslaught marched on. Now, with an uptick in antibiotic-resistant bacteria reaching alarming proportions, Rockefeller University scientists have identified an enzyme produced in viruses (called bacteriophages) that could stop these one-celled powerhouses dead in their tracks.
Researchers identify biofilms that cause infections
Understanding the way bacterial cells "talk" to each other could lead to more effective methods for fighting the often persistent and serious infections caused by the biofilms they form, says a Texas A&M University professor of chemical engineering who not only has deciphered their language but also discovered how to quell their conversation.
Despite vaccine, public should not get complacent about pneumococcal disease
Although the childhood pneumococcal conjugate vaccine has been a boon in reducing the incidence invasive pneumococcal disease (IPD), the public and the medical community must not get complacent, as non-vaccine strains, some resistant to antibiotics, are on the rise, say scientists at a meeting today in Boston.
Remote pools boost aboriginal child health
A new study has found that swimming pools in remote Aboriginal communities can dramatically reduce rates of skin, ear and chest infections.
Antibiotics do not appear helpful in preventing fluid buildup in children with ear infections
When prescribed to children with middle ear infections, antibiotics are not associated with a significant reduction in fluid buildup in the ear, according to a meta-analysis of previously published studies in the February issue of
Archives of Otolaryngology–Head & Neck Surgery, one of the JAMA/Archives journals.
Winemaking waste proves effective against disease-causing bacteria in early studies
Potential source of next-generation drugs against oral disease: Pinot noir
A class of chemicals in red wine grapes may significantly reduce the ability of bacteria to cause cavities, according to a study published recently in the Journal of Agricultural and Food Chemistry. The findings suggest that specific polyphenols, present in large amounts in fermented seeds and skins cast away after grapes are pressed, interfere with the ability of bacteria to contribute to tooth decay. Beyond cavities, the action of the wine grape-based chemicals may also hold clues for new ways to lessen the ability of bacteria to cause life-threatening, systemic infections.
UVic Biochemist Stares Down Superbug
University of Victoria biochemist Dr. Alisdair Boraston has discovered something new about a nasty superbug—a discovery that could lead to new drugs to combat it.
Aerosol launches immune response in lungs to wipe out lethal infections
An inhaled immune system stimulant protects mice against lethal pneumococcal pneumonia and other deadly bacterial, viral and fungal infections of the lungs, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports at a major scientific meeting.